Better treatment?

Better protection (Or exhaustion of supply) of most vulnerable?

Masks and/or enhanced cleaning limiting initial inoculum size?

Viral mutation to lower pathogenicity?

For whatever reason, the case fatality rate - once over 7% - is certainly coming down.